Elk Creek Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-2,356
| Closed | -$201K | – | 133 |
|
|
2018
Q4 | $201K | Sell |
2,356
-2,979
| -56% | -$254K | 0.02% | 133 |
|
|
2018
Q3 | $517K | Hold |
5,335
| – | – | 0.03% | 131 |
|
|
2018
Q2 | $503K | Sell |
5,335
-256
| -5% | -$24.1K | 0.03% | 136 |
|
|
2018
Q1 | $453K | Buy |
5,591
+817
| +17% | +$66.2K | 0.03% | 138 |
|
|
2017
Q4 | $426K | Buy |
4,774
+1,616
| +51% | +$144K | 0.03% | 140 |
|
|
2017
Q3 | $294K | Buy |
3,158
+77
| +2% | +$7.17K | 0.02% | 145 |
|
|
2017
Q2 | $280K | Hold |
3,081
| – | – | 0.02% | 148 |
|
|
2017
Q1 | $270K | Buy |
+3,081
| New | +$270K | 0.02% | 147 |
|
|
2016
Q4 | – | Sell |
-3,305
| Closed | -$306K | – | 151 |
|
|
2016
Q3 | $306K | Buy |
3,305
+326
| +11% | +$30.2K | 0.02% | 139 |
|
|
2016
Q2 | $232K | Sell |
2,979
-3,438
| -54% | -$268K | 0.02% | 142 |
|
|
2016
Q1 | $529K | Sell |
6,417
-746
| -10% | -$61.5K | 0.04% | 143 |
|
|
2015
Q4 | $750K | Sell |
7,163
-162
| -2% | -$17K | 0.05% | 136 |
|
|
2015
Q3 | $771K | Buy |
7,325
+1,433
| +24% | +$151K | 0.06% | 145 |
|
|
2015
Q2 | $806K | Sell |
5,892
-6,171
| -51% | -$844K | 0.07% | 139 |
|
|
2015
Q1 | $1.5M | Sell |
12,063
-4,746
| -28% | -$591K | 0.16% | 142 |
|
|
2014
Q4 | $1.52M | Buy |
+16,809
| New | +$1.52M | 0.2% | 138 |
|